Search research articles
Contact Us
Filters
Showing results (61-70 of 104) with videos related to
Page
of 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 9, 2024
A Phase 1 Trial of Image Guided Risk Volume-Adapted Postprostatectomy Radiation Therapy
Krishnan R Patel, Esther Mena, Lindsay S Rowe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 13, 2024
Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis
Seokjoo Kwon, Eun Joo Chung, Santwana Kc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2018
Hyperpolarized [1-<sup>13</sup>C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer <i>In Vivo</i> Predicts Efficacy of Targeting the Warburg Effect
Bradley T Scroggins, Masayuki Matsuo, Ayla O White, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2017
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage
Bradley T Scroggins, Jeffrey Burkeen, Ayla O White, et al.
Advances in Radiation Oncology
|
November 24, 2022
A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
Krishnan R Patel, Lindsay S Rowe, Erica Schott, et al.
Practical Radiation Oncology
|
July 13, 2023
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer
Krishnan R Patel, Nicholas R Rydzewski, Erica Schott, et al.
Oncogene
|
March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53
Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.
Radiation Oncology (London, England)
|
August 18, 2006
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost
Anurag K Singh, Peter Guion, Robert C Susil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2022
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
Tim E Phelps, Stephanie A Harmon, Esther Mena, et al.
Academic Radiology
|
July 9, 2025
A Deep Learning Model for Comprehensive Automated Bone Lesion Detection and Classification on Staging Computed Tomography Scans
Benjamin D Simon, Stephanie A Harmon, Dong Yang, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 104) with videos related to
Sort By:
Page
of 11
International Journal of Radiation Oncology, Biology, Physics
|
October 9, 2024
A Phase 1 Trial of Image Guided Risk Volume-Adapted Postprostatectomy Radiation Therapy
Krishnan R Patel, Esther Mena, Lindsay S Rowe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 13, 2024
Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis
Seokjoo Kwon, Eun Joo Chung, Santwana Kc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2018
Hyperpolarized [1-<sup>13</sup>C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer <i>In Vivo</i> Predicts Efficacy of Targeting the Warburg Effect
Bradley T Scroggins, Masayuki Matsuo, Ayla O White, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2017
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage
Bradley T Scroggins, Jeffrey Burkeen, Ayla O White, et al.
Advances in Radiation Oncology
|
November 24, 2022
A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
Krishnan R Patel, Lindsay S Rowe, Erica Schott, et al.
Practical Radiation Oncology
|
July 13, 2023
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer
Krishnan R Patel, Nicholas R Rydzewski, Erica Schott, et al.
Oncogene
|
March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53
Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.
Radiation Oncology (London, England)
|
August 18, 2006
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost
Anurag K Singh, Peter Guion, Robert C Susil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2022
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
Tim E Phelps, Stephanie A Harmon, Esther Mena, et al.
Academic Radiology
|
July 9, 2025
A Deep Learning Model for Comprehensive Automated Bone Lesion Detection and Classification on Staging Computed Tomography Scans
Benjamin D Simon, Stephanie A Harmon, Dong Yang, et al.
Page
of 11